Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 25, 2022

SELL
$2.85 - $3.73 $25,963 - $33,980
-9,110 Closed
0 $0
Q4 2021

Jan 10, 2022

BUY
$3.24 - $5.18 $19,472 - $31,131
6,010 Added 193.87%
9,110 $30,000
Q3 2021

Oct 13, 2021

SELL
$3.94 - $5.84 $35,460 - $52,560
-9,000 Reduced 74.38%
3,100 $15,000
Q2 2021

Jul 14, 2021

BUY
$4.26 - $6.5 $2,130 - $3,250
500 Added 4.31%
12,100 $52,000
Q1 2021

Apr 12, 2021

BUY
$5.03 - $8.8 $58,096 - $101,640
11,550 Added 23100.0%
11,600 $72,000
Q2 2020

Jul 10, 2020

SELL
$4.78 - $8.26 $28,680 - $49,560
-6,000 Reduced 99.17%
50 $0
Q1 2020

Apr 09, 2020

BUY
$4.0 - $21.53 $24,000 - $129,180
6,000 Added 12000.0%
6,050 $24,000
Q4 2019

Jan 10, 2020

SELL
$13.94 - $24.12 $174,250 - $301,500
-12,500 Reduced 99.6%
50 $1,000
Q3 2019

Oct 25, 2019

BUY
$13.89 - $23.16 $173,736 - $289,685
12,508 Added 29780.95%
12,550 $190,000
Q2 2019

Jul 24, 2019

SELL
$16.27 - $20.51 $73,556 - $92,725
-4,521 Reduced 99.08%
42 $0
Q1 2019

Apr 17, 2019

SELL
$12.61 - $22.33 $68,560 - $121,408
-5,437 Reduced 54.37%
4,563 $94,000
Q4 2018

Jan 22, 2019

SELL
$12.41 - $22.98 $186,150 - $344,700
-15,000 Reduced 60.0%
10,000 $136,000
Q2 2018

Jul 18, 2018

BUY
$2.68 - $3.48 $67,000 - $87,000
25,000 New
25,000 $77,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.